eCART vs Avo
Epic, athenahealth and MEDITECH are the EHRs Avo's press release names among others, and its homepage says it can be layered on top of any EHR. That suits a health system that wants to author its own guideline logic without code and have it embedded in the chart. Avo also lists chart assistants and an ambient scribe as products, and it sells by demo.
AgileMD pairs Clinical Pathways, with order entry from a pathway, calculators and generated documentation, with eCART, an FDA-cleared early warning score for hospitalized ward patients. Its homepage promises native EHR workflows and names no EHR, while Avo's release puts MEDITECH in writing, so a community hospital on MEDITECH that wants pathway order sets inside the chart finds its EHR named in Avo's materials and not in AgileMD's. A hospital whose first need is ward deterioration scoring is AgileMD's buyer, because only AgileMD lists a cleared deterioration score, K233253, and Avo's homepage and release make no FDA claim for its decision support, chart assistants, scribe or chatbot.
Decision support · Reviewed November 2, 2026
When to pick each one
eCART
- Pathway order entry, calculators and generated documentation
- Early warning score from the same vendor
Avo
- No-code guideline CDS authored by the health system
- Epic, athenahealth and MEDITECH named among others
- Chart assistants and ambient scribe listed as products
Score
Each row shows points earned of points available under the published rubric.
eCART
56of 100
Avo
18of 100
| Dimension | eCART | Avo | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 0 / 12 | +12 |
| HIPAA / SOC2 / BAA | 10 / 10 | 6 / 10 | +4 |
| EHR integrations (count) | 0 / 5.6 | 1.7 / 5.6 | -1.7 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 3.4 / 4.8 | -3.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 21 / 21 | 0 / 21 | +21 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
eCART
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. There is no pricing page; the site offers a demo request only. |
Avo
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The pricing page returns 404; the site offers a demo booking only. |
Evidence
eCART
FDA decisions
K233253 (opens in new tab)510(k)2024-06-21
eCARTv5 Clinical Deterioration Suite (eCART)
Peer-reviewed
5 PubMed records name eCART.
- Early Warning Scores With and Without Artificial Intelligence. (opens in new tab)
- Multicenter Development and Prospective Validation of eCARTv5: A Gradient Boosted Machine Learning Early Warning Score. (opens in new tab)
- DETERIO-LLM: enhancing traditional deterioration risk scores with clinical context and advanced reasoning. (opens in new tab)
Avo
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | eCART | Avo |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Epic, athenahealth, MEDITECH |
| Founded | n/a | n/a |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.


